![](/img/cover-not-exists.png)
A phase III study of VP16 plus cisplatin (VP) alone or with ifosfamide (VIP) in previously untreated patients (pts) with extensive small cell carcinoma of the lung (SCLC): A hoosier oncology group trial
Volume:
11
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/0169-5002(94)92150-4
Date:
June, 1994
File:
PDF, 98 KB
english, 1994